Apeloa Pharmaceutical Co., Ltd.
Founded in 1989, ProPharmaceuticals (stock code: 000739) ranks among the top 36 pharmaceutical industry enterprises in China, the second in "API Export", the top 5 small molecule CDMO companies in China, the top 100 "China's Most Promising Listed Companies", a leading biopharmaceutical enterprise in Zhejiang Province and an "Eagle Enterprise" in Zhejiang Province. The main business involves APIs, CDMOs, pharmaceuticals, medical beauty and cosmetic raw materials, and various business sectors.
Founded in 1989, ProPharmaceuticals (stock code: 000739) ranks among the top 36 pharmaceutical industry enterprises in China, the second in "API Export", the top 5 small molecule CDMO companies in China, the top 100 "China's Most Promising Listed Companies", a leading biopharmaceutical enterprise in Zhejiang Province and an "Eagle Enterprise" in Zhejiang Province. The main business involves APIs, CDMOs, pharmaceuticals, medical beauty and cosmetic raw materials, and the high-quality development of various business segments shows new bright colors.
- Type
- Manufacturer
- Location
- China
- Website
- https://www.apeloa.com
- Categories
- Skincare & Cosmetics
- Markets
- China
Listed in a source registry
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-04 Mail server of the company domain
- domain-registered (green), checked 2026-08-04 Domain registry record
- web-presence-since (green), checked 2026-08-02 Internet Archive (Wayback)
- lei-lapsed (amber), checked 2026-08-04 GLEIF
- debarment-clear (green), checked 2026-08-04 OpenSanctions
- sanctions-clear (green), checked 2026-08-04 OpenSanctions
Import rules for these goods
- Cosmetic products must be notified in the EU Cosmetic Products Notification Portal (CPNP) before being placed on the EU market. European Commission (CPNP)
- For the US market, MoCRA requires cosmetic facility registration and product listing with the FDA. US FDA (MoCRA)